High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study

This publication has 19 references indexed in Scilit:

• High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.
  Journal of Clinical Oncology, 1995
• Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor a randomized trial
  Cancer, 1993
• Peripheral blood stem cell transplantation for breast cancer patients with bone marrow metastases using GM-CSF priming
  Transfusion Science, 1993
• A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.
  Journal of Clinical Oncology, 1992
• GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols
  Breast Cancer Research and Treatment, 1991
• Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activityin vivo
  International Journal of Cancer, 1991
• Bone marrow autotransplantation for solid tumors--prospects.
  Journal of Clinical Oncology, 1989
• Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapy
  Cancer Chemotherapy and Pharmacology, 1988
• High-dose i.v. thiotepa and cryopreserved autologous bone marrow transplantation for therapy of refractory cancer.
  1987
• Phase I-II study of high-dose mitomycin with autologous bone marrow transplantation in refractory metastatic breast cancer.
  1984